These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Pathogenesis of herpes simplex keratitis: The host cell response and ocular surface sequelae to infection and inflammation. Lobo AM; Agelidis AM; Shukla D Ocul Surf; 2019 Jan; 17(1):40-49. PubMed ID: 30317007 [TBL] [Abstract][Full Text] [Related]
6. Pathological processes activated by herpes simplex virus-1 (HSV-1) infection in the cornea. Koujah L; Suryawanshi RK; Shukla D Cell Mol Life Sci; 2019 Feb; 76(3):405-419. PubMed ID: 30327839 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the antiviral potential of the soluble forms of glycoprotein D receptors on ocular herpes caused by HSV-1 and HSV-2 infections in a transgenic mouse model. Fujimoto Y; Hikita SI; Takeda K; Ozaki K; Inoue H; Takakuwa H; Sonoda KH; Ono E J Med Virol; 2019 May; 91(5):820-828. PubMed ID: 30575982 [TBL] [Abstract][Full Text] [Related]
8. [Herpes simplex virus latency, reactivation, and a new antiviral therapy for herpetic keratitis]. Shimomura Y Nippon Ganka Gakkai Zasshi; 2008 Mar; 112(3):247-64; discussion 265. PubMed ID: 18411713 [TBL] [Abstract][Full Text] [Related]
9. Acyclovir in the Treatment of Herpes Viruses - A Review. Kłysik K; Pietraszek A; Karewicz A; Nowakowska M Curr Med Chem; 2020; 27(24):4118-4137. PubMed ID: 29521211 [TBL] [Abstract][Full Text] [Related]
10. Ocular herpes simplex: changing epidemiology, emerging disease patterns, and the potential of vaccine prevention and therapy. Pepose JS; Keadle TL; Morrison LA Am J Ophthalmol; 2006 Mar; 141(3):547-557. PubMed ID: 16490506 [TBL] [Abstract][Full Text] [Related]
11. Herpesvirus entry mediator on radiation-resistant cell lineages promotes ocular herpes simplex virus 1 pathogenesis in an entry-independent manner. Edwards RG; Kopp SJ; Karaba AH; Wilcox DR; Longnecker R mBio; 2015 Oct; 6(5):e01532-15. PubMed ID: 26489863 [TBL] [Abstract][Full Text] [Related]
12. A new promising candidate to overcome drug resistant herpes simplex virus infections. Zinser E; Krawczyk A; Mühl-Zürbes P; Aufderhorst U; Draßner C; Stich L; Zaja M; Strobl S; Steinkasserer A; Heilingloh CS Antiviral Res; 2018 Jan; 149():202-210. PubMed ID: 29155164 [TBL] [Abstract][Full Text] [Related]
13. Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease. Davido DJ; Tu EM; Wang H; Korom M; Gazquez Casals A; Reddy PJ; Mostafa HH; Combs B; Haenchen SD; Morrison LA J Virol; 2018 Sep; 92(17):. PubMed ID: 29950407 [TBL] [Abstract][Full Text] [Related]
14. An M2 Rather than a T Lee DH; Ghiasi H J Virol; 2018 May; 92(10):. PubMed ID: 29491152 [TBL] [Abstract][Full Text] [Related]